Evidence map›Paper›PMID 36981543›Full record

ArticleHealthcare (Basel, Switzerland)2023

Effectiveness of Transition Care Intervention Targeted to High-Risk Patients to Reduce Readmissions: Study Protocol for the TARGET-READ Multicenter Randomized-Controlled Trial.

Alexandre Gouveia, Marco Mancinetti, Daniel Genné, Marie Méan, Gregor John, Lukas Bütikofer, Drahomir Aujesky, Jeffrey L Schnipper, Jacques Donzé

Open access · goldFull text read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Alexandre GouveiaDepartment of Ambulatory Care, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland.ORCID 0000-0002-5798-0092
Marco MancinettiDepartment of Internal Medicine, HFR-Fribourg Cantonal Hospital, Chem. des Pensionnats 2-6, 1752 Villars-sur-Glâne, Switzerland.ORCID 0000-0001-6335-1375
Daniel GennéDepartment of Internal Medicine, Bienne Hospital Center, Chante-Merle 84, 2501 Bienne, Switzerland.
Marie MéanDivision of Internal Medicine, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland.
Gregor JohnDepartment of Internal Medicine, Neuchâtel Hospital Network, Rue de la Maladière 45, 2000 Neuchâtel, Switzerland.ORCID 0000-0002-1548-7339
Lukas BütikoferClinical Trials Unit Bern, Faculty of Medicine, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland.ORCID 0000-0002-0801-746X
Drahomir AujeskyDepartment of Internal Medicine, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.
Jeffrey L SchnipperDivision of General Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont St. BC-3, Boston, MA 02120, USA.
Jacques DonzéDepartment of Internal Medicine, Neuchâtel Hospital Network, Rue de la Maladière 45, 2000 Neuchâtel, Switzerland.ORCID 0000-0003-4147-6497
University of Bern · CHBrigham and Women's Hospital · USCentre universitaire de médecine générale et santé publique, Lausanne · CHFribourg Development Agency · CHHospital Neuchâtel · CHSpitalzentrum Centre hospitalier Biel- Bienne · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital readmissions within 30 days represent a burden for the patients and the entire health care system. Improving the care around hospital discharge period could decrease the risk of avoidable readmissions. We describe the methods of a trial that aims to evaluate the effect of a structured multimodal transitional care intervention targeted to higher-risk medical patients on 30-day unplanned readmissions and death. The TARGET-READ study is an investigator-initiated, pragmatic single-blinded randomized multicenter controlled trial with two parallel groups. We include all adult patients at risk of hospital readmission based on a simplified HOSPITAL score of ≥4 who are discharged home or nursing home after a hospital stay of one day or more in the department of medicine of the four participating hospitals. The patients randomized to the intervention group will receive a pre-discharge intervention by a study nurse with patient education, medication reconciliation, and follow-up appointment with their referring physician. They will receive short follow-up phone calls at 3 and 14 days after discharge to ensure medication adherence and follow-up by the ambulatory care physician. A blind study nurse will collect outcomes at 1 month by phone call interview. The control group will receive usual care. The TARGET-READ study aims to increase the knowledge about the efficacy of a bundled intervention aimed at reducing 30-day hospital readmission or death in higher-risk medical patients.

Indexed as

coordination of carehospital admissionhospital dischargehospital readmissionmedication reconciliationpatient educationtransitional caretransitions of care

Identifiers

PMID36981543
PMCPMC10048511
OpenAlexW4327949236

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read20
identifiers read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.